Skip to main content
. 2020 Oct 7;7:100055. doi: 10.1016/j.ijchy.2020.100055

Table 1.

Relative increase in prevalence, age group, and gender-wise.

Age (years) Prevalence (JNC 8) (%) Prevalence (2017 ACC/AHA) (%) Difference (2017 ACC/AHA but not JNC8) Relative increase (%)
Men
18-19 (n ​= ​5,448) 16.1 (15.1, 17.08) 48.7 (47.4, 50) 32.6 202.5
20-44 (n ​= ​66,039) 26.7 (26.4, 27) 65.4 (65, 65.8) 38.7 144.9
45-54 (n ​= ​23,789) 42.4 (41.8, 43) 76.9 (76.4, 77.4) 34.5 81.4
55-64 (n ​= ​15,874) 49 (48.2, 49.8) 79.7 (79.1, 80.3) 30.7 62.7
65-74 (n ​= ​7,181) 51.5 (50.3, 52.7) 80.6 (79.7, 81.5) 29.1 56.5
≥75 (n ​= ​2,094) 52.2 (50.1, 54.3) 78.5 (76.7, 80.3) 26.3 50.4
Overall 39.4 (39.1, 39.7) 69.9 (69.9, 70.2) 30.2 76.6
Women
18-19 (n ​= ​3450) 6.2 (5.4, 7) 30.5 (29, 32) 24.3 391.9
20-44 (n ​= ​33,753) 14 (13.6, 14.4) 45.6 (45.1, 46.1) 31.6 225.7
45-54 (n ​= ​11,905) 34.6 (33.8, 35.5) 69.1 (68.3, 69.9) 34.5 99.7
55-64 (n ​= ​7,210) 45.4 (44.3, 46.6) 76.6 (75.6, 77.6) 31.2 68.7
65-74 (n ​= ​2,808) 51.4 (49.6, 53.3) 78.2 (76.7, 79.7) 26.8 52.1
≥75 (n ​= ​784) 51.3 (47.8, 54.8) 79.7 (76.9, 82.5) 28.4 55.4
Overall 29.3 (28.9, 29.7) 48 (47.6, 48.4) 18.7 63.8

ACC/AHA ​= ​American College of Cardiology/American Heart Association; JNC8 ​= ​8th Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.